Combo Products Administrative Fixes Helpful, But Not Enough – Medtronic

The appointment of a director of combination products within FDA ombudsman's office should be backed by the ability to set policy and chart review performance, Medtronic writes in comments to the HHS Secretary's Advisory Committee on Regulatory Reform